Validation of a High-Throughput Dicentric Chromosome Assay Using Complex Radiation Exposures.
Journal
Radiation research
ISSN: 1938-5404
Titre abrégé: Radiat Res
Pays: United States
ID NLM: 0401245
Informations de publication
Date de publication:
01 01 2023
01 01 2023
Historique:
received:
21
12
2021
accepted:
24
10
2022
pmc-release:
01
01
2024
pubmed:
23
8
2022
medline:
12
1
2023
entrez:
22
8
2022
Statut:
ppublish
Résumé
Validation of biodosimetry assays is routinely performed using primarily orthovoltage irradiators at a conventional dose rate of approximately 1 Gy/min. However, incidental/ accidental exposures caused by nuclear weapons can be more complex. The aim of this work was to simulate the DNA damage effects mimicking those caused by the detonation of a several kilotons improvised nuclear device (IND). For this, we modeled complex exposures to: 1. a mixed (photons + IND-neutrons) field and 2. different dose rates that may come from the blast, nuclear fallout, or ground deposition of radionuclides (ground shine). Additionally, we assessed whether myeloid cytokines affect the precision of radiation dose estimation by modulating the frequency of dicentric chromosomes. To mimic different exposure scenarios, several irradiation systems were used. In a mixed field study, human blood samples were exposed to a photon field enriched with neutrons (ranging from 10% to 37%) from a source that mimics Hiroshima's A-bomb's energy spectrum (0.2-9 MeV). Using statistical analysis, we assessed whether photons and neutrons act in an additive or synergistic way to form dicentrics. For the dose rates study, human blood was exposed to photons or electrons at dose rates ranging from low (where the dose was spread over 32 h) to extremely high (where the dose was delivered in a fraction of a microsecond). Potential effects of cytokine treatment on biodosimetry dose predictions were analyzed in irradiated blood subjected to Neupogen or Neulasta for 24 or 48 h at the concentration recommended to forestall manifestation of an acute radiation syndrome in bomb survivors. All measurements were performed using a robotic station, the Rapid Automated Biodosimetry Tool II, programmed to culture lymphocytes and score dicentrics in multiwell plates (the RABiT-II DCA). In agreement with classical concepts of radiation biology, the RABiT-II DCA calibration curves suggested that the frequency of dicentrics depends on the type of radiation and is modulated by changes in the dose rate. The resulting dose-response curves suggested an intermediate dicentric yields and additive effects of photons and IND-neutrons in the mixed field. At ultra-high dose rate (600 Gy/s), affected lymphocytes exhibited significantly fewer dicentrics (P < 0.004, t test). In contrast, we did not find the dose-response modification effects of radiomitigators on the yields of dicentrics (Bonferroni corrected P > 0.006, ANOVA test). This result suggests no bias in the dose predictions should be expected after emergency cytokine treatment initiated up to 48 h prior to blood collection for dicentric analysis.
Identifiants
pubmed: 35994701
pii: 485314
doi: 10.1667/RADE-22-00007.1
pmc: PMC9947868
mid: NIHMS1864091
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-16Subventions
Organisme : NIAID NIH HHS
ID : HHSN272201600040C
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI067773
Pays : United States
Informations de copyright
© 2023 by Radiation Research Society. All rights of reproduction in any form reserved.
Références
Front Cell Dev Biol. 2021 Apr 29;9:672693
pubmed: 33996830
Radiat Environ Biophys. 2017 Mar;56(1):79-87
pubmed: 28144741
Sci Rep. 2020 Feb 19;10(1):2899
pubmed: 32076014
Radiat Res. 1996 Sep;146(3):247-58
pubmed: 8752302
Front Oncol. 2021 May 25;11:644400
pubmed: 34113566
Br J Radiol. 2022 May 01;95(1133):20211150
pubmed: 35171701
Radiother Oncol. 2021 Sep;162:68-75
pubmed: 34214612
J Radiat Res. 2011;52(1):75-81
pubmed: 21160135
Front Oncol. 2021 Jul 29;11:686142
pubmed: 34395253
Braz J Med Biol Res. 2015 Oct;48(10):908-14
pubmed: 26445334
Phys Med Biol. 2019 Sep 11;64(18):185005
pubmed: 31365907
Cell. 2015 Dec 17;163(7):1641-54
pubmed: 26687355
Radiat Res. 2020 Nov 1;196(5):501-509
pubmed: 33022052
Int J Radiat Biol Relat Stud Phys Chem Med. 1976 Feb;29(2):169-82
pubmed: 1083382
Health Phys. 2010 Feb;98(2):276-81
pubmed: 20065694
BMC Genomics. 2018 Jun 28;19(1):504
pubmed: 29954325
Nucl Instrum Methods Phys Res A. 2015 Sep 11;794:234-239
pubmed: 26273118
EXCLI J. 2020 Aug 18;19:1172-1173
pubmed: 33088256
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8293-8
pubmed: 21527720
PLoS One. 2015 Mar 20;10(3):e0121083
pubmed: 25794041
Radiat Environ Biophys. 2012 Aug;51(3):283-93
pubmed: 22526916
Radiat Environ Biophys. 2006 Jul;45(2):79-91
pubmed: 16807767
Sci Rep. 2019 Nov 27;9(1):17649
pubmed: 31776470
Radiat Meas. 2011 Sep 1;46(9):923-928
pubmed: 21949482
Front Oncol. 2020 Jan 17;9:1563
pubmed: 32010633
Radiat Res. 1991 Oct;128(1 Suppl):S147-52
pubmed: 1924742
Expert Rev Mol Med. 2022 Feb 28;24:e10
pubmed: 35225211
Sci Rep. 2020 Nov 16;10(1):19899
pubmed: 33199728
Blood. 2003 Jul 15;102(2):734-9
pubmed: 12676791
Health Phys. 2010 Feb;98(2):172-8
pubmed: 20065680
PLoS One. 2018 Oct 31;13(10):e0204068
pubmed: 30379881
J Med Genet. 1974 Jun;11(2):181-9
pubmed: 4841086
Mutat Res. 2013 Aug 30;756(1-2):95-100
pubmed: 23669292
Nat Commun. 2018 Oct 18;9(1):4340
pubmed: 30337534
Health Phys. 1981 Oct;41(4):666-71
pubmed: 7309524
Nucleic Acids Res. 2013 Sep;41(16):7589-605
pubmed: 23804754
Health Phys. 2010 Feb;98(2):290-5
pubmed: 20065696
Radiat Res. 2021 May 1;195(5):480-496
pubmed: 33587743
Sci Rep. 2021 Feb 17;11(1):4022
pubmed: 33597632
Radiat Res. 2021 Jul 1;196(1):31-39
pubmed: 33857301
Health Phys. 2018 Dec;115(6):743-759
pubmed: 33289997
Radiat Prot Dosimetry. 2019 Dec 31;186(1):15-23
pubmed: 31330012
J Radiol Prot. 2012 Sep;32(3):261-75
pubmed: 22809710
Radiat Res. 2019 Aug;192(2):189-199
pubmed: 31237816
Clin Exp Immunol. 2016 Jul;185(1):107-18
pubmed: 26990855
Clin Oncol (R Coll Radiol). 2019 Jul;31(7):407-415
pubmed: 31010708
Sci Rep. 2022 Dec 22;12(1):22149
pubmed: 36550150
Front Pharmacol. 2021 May 10;12:624844
pubmed: 34040517
Chromosome Res. 2013 Jul;21(4):407-18
pubmed: 23793898
Nat Rev Cancer. 2006 Oct;6(10):813-23
pubmed: 16990858
Radiat Res. 2011 Jun;175(6):719-27
pubmed: 21438661
Br J Radiol. 2020 Feb 01;93(1106):20190702
pubmed: 31825653
Radiat Res. 2017 Oct;188(4):400-411
pubmed: 28820355
Radiat Prot Dosimetry. 2016 Dec;172(1-3):58-71
pubmed: 27886989
Radiat Environ Biophys. 2016 Mar;55(1):53-9
pubmed: 26791381
Disaster Med Public Health Prep. 2011 Mar;5 Suppl 1:S32-44
pubmed: 21402810
Molecules. 2014 Apr 16;19(4):4770-8
pubmed: 24743934
Radiat Res. 2017 Apr;187(4):465-475
pubmed: 28211757
Radiat Res. 2020 Jun 1;193(6):506-511
pubmed: 32315248
J Radiat Res. 2016 Nov;57(6):583-595
pubmed: 27614201
Med Phys. 2022 Mar;49(3):1993-2013
pubmed: 34426981
Int J Radiat Biol Relat Stud Phys Chem Med. 1975 Jul;28(1):75-90
pubmed: 1081092
Radiat Res. 2019 Jul;192(1):99-120
pubmed: 31081742
Immunity. 1999 Aug;11(2):153-61
pubmed: 10485650
Radiat Res. 2019 Sep;192(3):311-323
pubmed: 31295087
Phys Med Biol. 2009 Oct 7;54(19):N433-8
pubmed: 19724100
Health Phys. 2019 Mar;116(3):339-353
pubmed: 30281533
Br J Ind Med. 1977 Nov;34(4):261-73
pubmed: 338021
Sci Rep. 2021 Feb 8;11(1):3341
pubmed: 33558553
Int J Radiat Biol. 2019 Jun;95(6):725-736
pubmed: 30821557
Radiat Res. 2015 Oct;184(4):404-10
pubmed: 26414507
Cytokine. 2015 Jan;71(1):22-37
pubmed: 25215458
Trends Genet. 2022 Jul;38(7):641-645
pubmed: 35397934
Sci Rep. 2019 Mar 14;9(1):4539
pubmed: 30872747
Clin Cancer Res. 2020 Mar 15;26(6):1497-1506
pubmed: 31796518
Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):574-586
pubmed: 33412259
Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):240-248
pubmed: 33845146